Meta-Analysis on the Anesthetic Effects of Remifentanil plus Dexmedetomidine versus Remifentanil Alone in Cardiac Surgery,Computational and Mathematical Methods in Medicine

当前位置： X-MOL 学术 › Comput. Math. Method Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Meta-Analysis on the Anesthetic Effects of Remifentanil plus Dexmedetomidine versus Remifentanil Alone in Cardiac Surgery
Computational and Mathematical Methods in Medicine ( IF 2.809 ) Pub Date : 2022-9-28 , DOI: 10.1155/2022/1077980
Xiao-Lin Zeng ₁ , Jun-Hua Liao ₂ , Hui-Sheng Zhong ₃ , Xin-Hua Yin ₁ , Rui Wang ₁ , Jiu-Ping Liang ₄ , Zheng-Sheng Zhang ₅

Affiliation

In this study, we performed a meta-analysis to investigate the anesthesia effects of remifentanil plus dexmedetomidine versus remifentanil alone in cardiac surgery. Literature search was performed on PubMed, Web of Science, Embase, China Knowledge Infrastructure, Wanfang Data, and other databases for relevant literature published in English or Chinese before October 2021. A total of 17 studies, consisting of 1350 patients, were included in this study. Of these, 10 studies showed that remifentanil plus dexmedetomidine had a good anesthesia effect in cardiac surgery (, 95% CI: 1.73, 7.52, ), and 8 studies showed that the Ramsay score test of anesthesia (; 95% CI: -0.77, 2.53; ) in the experimental group was better than that in the control group. In addition, changes in the hemodynamic heart rate (; 95% CI: -1.41, -0.07; ) and mean arterial pressure (; 95% CI: -0.72, 0.36; ) of the two groups of anesthesia were counted in 17 studies, which also showed that the anesthesia effect of remifentanil plus dexmedetomidine was good. Thus, remifentanil plus dexmedetomidine may be a more promising option for cardiac surgery anesthesia than remifentanil alone.

更新日期：2022-09-28

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>